FEI Tribunal Issues Decision on Salahdin Du Lauragais Case
Edited Press Release
September 18, 2015
Salahdin Du Lauragais tested positive for the banned substance reserpine, a long-lasting tranquilizer.
Salahdin Du Lauragais tested positive for the banned substance reserpine, a long-lasting tranquilizer.
The committee will begin work immediately and report to the ARCI Board of Directors in December.
Nikki Scherrer, DVM, will cover horse health issues related to shows, such as medications, emergencies, and regulations.
The projects will investigate EIPH’s pathophysiology and the effect of the medication furosemide on that condition.
Mike Repole, Starlight Racing, and StarLadies Racing become Foundation Donors of the program’s capital campaign.
Hallvard Sommerseth, DVM, was suspended for noncompliance with the FEI Rules and Regulations.
Horsemen will have the opportunity to pledge a percentage of their earnings to Thoroughbred Charities of America (TCA).
The research will begin once the five Standardbreds to be used in the study have cleared a routine quarantine.
Belterra will celebrate Old Friends, the Thoroughbred retirement facility that cares for more than 150 ex-racehorses.
A portion of the proceeds from a special seating option will benefit the Georgetown, Kentucky-based nonprofit.
The triple quadrupole mass spectrometer will be used to screen for new drugs alleged to be used in horse racing.
The FEI is preparing to launch the global Equine Anti-Doping and Controlled Medication Program on Jan. 1, 2016.
After 60 days of racing, all of the 221 samples tested were beneath the of 25 ppb (parts per billion) threshold.
Risk factors for equine nosebleeds appear to include age at first start, running on firm ground, and more.
Glen Hill Farm’s sponsorship of the stakes race will benefit the Grayson-Jockey Club Research Foundation.
The experts agree that research results could evolve into standards that can help protect horses and riders.
Stay on top of the most recent Horse Health news with
